Lexicon Pharmaceuticals (NASDAQ:LXRX) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on LXRX. Leerink Partnrs cut shares of Lexicon Pharmaceuticals from a “strong-buy” rating to a “hold” […]